Charité Universitätsmedizin Berlin (partner, CHAR)

Established in 1710, Charité Universitätsmedizin Berlin is one of the largest university hospitals in Europe with close to 100 different Departments and Institutes and more than 3,700 researchers. It combines research, teaching and clinical care. It lays claim to more than half of all German Nobel Prize winners in Physiology or Medicine, including Emil von Behring, Robert Koch, and Paul Ehrlich. CHAR coordinated five graduate colleges of the German Research Foundation. CHAR actively participated in several FP7 consortia and coordinated more than 20 European projects, including the ITN RADOX.

The Institute for Microbiology, Infectious Disease, and Immunology
The institute is headed by professor A. Diefenbach, a world leading specialist in Microbiology and Immunology, who is among the highly cited researchers in the Web of Science. The institute currently hosts nine working groups including three ERC grantees and one Emmy-Noether-Programme Recipient. The scientists at the Institute of Microbiology, Infectious Diseases and Immunology aim to perform groundbreaking research into the interactions between microorganisms and the innate immune system, in particular at border surfaces with the environment.


Dr. Annette Moter, MD is clinical microbiologist and the head of the Biofilm Centerat the Department of Microbiology, Infectious Disease, and Immunology at the Charité Universitätsklinik Berlin. Her research is focused on revealing molecular and structural insights into microbial communities in complex medical samples ranging from biofilms in the oral cavity, on heart valves, to wounds and device-associated infections. She is currently supervising the graduation of 2 master students, 3 MD students and 1 PhD student. She is PI in the project iSOLID of the German Federal Ministry of Education and Science (BMBF), and was awarded the Rusche award of the German Foundation for Heart Research together with Prof. Lauten of Charité. She is head of the German National Consiliary Laboratory for diagnosis of Tropheryma whipplei appointed by the Robert Koch-Institute. The publication “Potential role for urine PCR in the diagnosis of Whipple’s disease” in Clinical Infectious Diseases was appointed “Paper of the Month January 2019” by the German Association of Hygiene and Microbiology (DGHM). Dr. Moter held the vice chair of COST action TD1305 iPROMEDAI, leading its focus group cardiovascular devices. She is in the Editorial board of npj: Biofilms and Microbiomes, Nature Partner Journals Springer Nature and co-author on the German S3 Guideline on antibiotic therapy of periodontitis 2019. Besides scientific honours, she was awarded for Family-Friendly Charité in 2014.

Dr. Judith Kikhney, PhD.
Dr. Moter is also beneficiary, together with Dr. Judith Kikhney, PhD. Biology, CEO of the German Federal Ministry of Economic Affairs and Energy with a start-up project (EXIST Research Transfer) and have started in 2017 their company MoKi Analytics GmbH. Together they won the first prize of the Innovation Award “Research to Market Challenge” of Charité Stiftung, Entrepreneurship Summit 2014. MoKi Analytics is currently nominated for the Deutsche Gründerpreis (German Start-Up Award) 2020.